These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22931058)

  • 1. Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development.
    Zaloumis S; Humberstone A; Charman SA; Price RN; Moehrle J; Gamo-Benito J; McCaw J; Jamsen KM; Smith K; Simpson JA
    Malar J; 2012 Aug; 11():303. PubMed ID: 22931058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.
    Staehli Hodel EM; Guidi M; Zanolari B; Mercier T; Duong S; Kabanywanyi AM; Ariey F; Buclin T; Beck HP; Decosterd LA; Olliaro P; Genton B; Csajka C
    Malar J; 2013 Jul; 12():235. PubMed ID: 23841950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring windows of selection for anti-malarial drug treatments.
    Kay K; Hastings IM
    Malar J; 2015 Jul; 14():292. PubMed ID: 26228915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria.
    Muhindo MK; Kakuru A; Jagannathan P; Talisuna A; Osilo E; Orukan F; Arinaitwe E; Tappero JW; Kaharuza F; Kamya MR; Dorsey G
    Malar J; 2014 Jan; 13():32. PubMed ID: 24468007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling.
    Hodel EM; Kay K; Hayes DJ; Terlouw DJ; Hastings IM
    Malar J; 2014 Apr; 13():138. PubMed ID: 24708571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Lefèvre G; Looareesuwan S; Treeprasertsuk S; Krudsood S; Silachamroon U; Gathmann I; Mull R; Bakshi R
    Am J Trop Med Hyg; 2001; 64(5-6):247-56. PubMed ID: 11463111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.
    Lim P; Alker AP; Khim N; Shah NK; Incardona S; Doung S; Yi P; Bouth DM; Bouchier C; Puijalon OM; Meshnick SR; Wongsrichanalai C; Fandeur T; Le Bras J; Ringwald P; Ariey F
    Malar J; 2009 Jan; 8():11. PubMed ID: 19138391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
    Sirima SB; Ogutu B; Lusingu JPA; Mtoro A; Mrango Z; Ouedraogo A; Yaro JB; Onyango KO; Gesase S; Mnkande E; Ngocho JS; Ackermann I; Aubin F; Vanraes J; Strub N; Carn G
    Lancet Infect Dis; 2016 Oct; 16(10):1123-1133. PubMed ID: 27430374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
    Gerardin J; Eckhoff P; Wenger EA
    BMC Infect Dis; 2015 Mar; 15():144. PubMed ID: 25887935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.
    Mosha D; Guidi M; Mwingira F; Abdulla S; Mercier T; Decosterd LA; Csajka C; Genton B
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4583-92. PubMed ID: 24867986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?
    Hastings IM; Kay K; Hodel EM
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6428-36. PubMed ID: 26239987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro sensitivity of Plasmodium falciparum to lumefantrine in north-western Thailand.
    Pilz JB; Wernsdorfer G; Sirichaisinthop J; Rojanawatsirivet C; Wiedermann G; Wernsdorfer WH
    Wien Klin Wochenschr; 2004; 116 Suppl 4():41-6. PubMed ID: 15683042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness.
    Kay K; Hodel EM; Hastings IM
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6419-27. PubMed ID: 26239993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic profile of artemisinin derivatives and companion drugs used in artemisinin-based combination therapies for the treatment of Plasmodium falciparum malaria in children.
    Pawluk SA; Wilby KJ; Ensom MH
    Clin Pharmacokinet; 2013 Mar; 52(3):153-67. PubMed ID: 23288505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.
    Ursing J; Kofoed PE; Rodrigues A; Blessborn D; Thoft-Nielsen R; Björkman A; Rombo L
    J Infect Dis; 2011 Jan; 203(1):109-16. PubMed ID: 21148503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.
    Amaratunga C; Lim P; Suon S; Sreng S; Mao S; Sopha C; Sam B; Dek D; Try V; Amato R; Blessborn D; Song L; Tullo GS; Fay MP; Anderson JM; Tarning J; Fairhurst RM
    Lancet Infect Dis; 2016 Mar; 16(3):357-65. PubMed ID: 26774243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative, randomized clinical trial of artemisinin/naphtoquine twice daily one day versus artemether/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire.
    Toure OA; Penali LK; Yapi JD; Ako BA; Toure W; Djerea K; Gomez GO; Makaila O
    Malar J; 2009 Jul; 8():148. PubMed ID: 19575797
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Zaloumis SG; Cao P; Dini S; Davenport MP; Cromer D; Khoury DS; Fowkes FJI; McCaw JM; Simpson JA
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.
    ; Pekyi D; Ampromfi AA; Tinto H; Traoré-Coulibaly M; Tahita MC; Valéa I; Mwapasa V; Kalilani-Phiri L; Kalanda G; Madanitsa M; Ravinetto R; Mutabingwa T; Gbekor P; Tagbor H; Antwi G; Menten J; De Crop M; Claeys Y; Schurmans C; Van Overmeir C; Thriemer K; Van Geertruyden JP; D'Alessandro U; Nambozi M; Mulenga M; Hachizovu S; Kabuya JB; Mulenga J
    N Engl J Med; 2016 Mar; 374(10):913-27. PubMed ID: 26962727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia.
    Satimai W; Sudathip P; Vijaykadga S; Khamsiriwatchara A; Sawang S; Potithavoranan T; Sangvichean A; Delacollette C; Singhasivanon P; Kaewkungwal J; Lawpoolsri S
    Malar J; 2012 Aug; 11():300. PubMed ID: 22929621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.